This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,419,063.00 to The Leland Stanford Junior University (Stanford University) to conduct research on synaptic retinoic acid signaling in spinal cord homeostatic plasticity and mechanical allodynia. The research, which will take place at Stanford University from September 1, 2023 to August 31, 2027, aims to transform healthcare for U.S. Service Members and...
The federal Project Grant award of $1,576,368 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) will fund an evaluation of electrical stimulation during nerve transfer surgery for cervical spinal cord injury at Stanford University. The grant, awarded on August 1, 2024, with a completion date of July 31, 2027, will support innovative research to develop advanced medical treatments for this condition. As a leading research institution,...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,191,941 to The Leland Stanford Junior University (Stanford University) from July 15, 2023 through July 14, 2027. The purpose of the grant is to conduct research on "Targeting Unusual Nutrient Acquisition Routes of Nutrient-Deprived Cancers." As a highly-regarded private research university, Stanford University has a history of providing...
This federal Project Grant award, valued at $548,519.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Leland Stanford Junior University (Stanford University) to conduct research on targeting the RSK protein for the treatment of pediatric acute myeloid leukemia. The award period is from September 15, 2023, to September 14, 2026. As a leading research university, Stanford University has significant experience...
The Leland Stanford Junior University has been awarded a $1,291,660.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on May 15, 2024, will fund foundational studies to understand phenotypic, region-specific, and cell-specific dysregulation in the myotonic dystrophy central nervous system, with a period of performance through May 14, 2028. This federal grant award supports the university's expertise in...
The U.S. Department of the Army Medical Command awarded The Leland Stanford Junior University (Stanford University) a $1,045,651 Project Grant on September 30, 2024 under the Military Medical Research and Development program (CFDA 12.420). The funding will support research to develop novel statistical methods for integrating high-dimensional clinical markers to evaluate treatment efficacy in amyotrophic lateral sclerosis (ALS) clinical trials. This research aims to transform health care for...
This federal Project Grant award of $4,232,760.00 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research initiatives at The Leland Stanford Junior University (Stanford University) to help transform healthcare for military service members and the general public. The goal of this 4-year award, which runs from June 1, 2025 to May 31, 2029, is to advance cure rates for infantile acute...
The Defense Health Agency awarded The Leland Stanford Junior University a $1,500,084 project grant under the Military Medical Research and Development program to support research on detecting cartilage surface degeneration using photon counting CT and solute transport modeling. This grant will fund research from July 1, 2023 through June 30, 2027 aimed at transforming military and public health care through innovative medical solutions applicable to battlefield conditions. The Military Medical...
The Leland Stanford Junior University (Stanford University) has been awarded a $370,866 federal Formula Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, titled "Uncovering Synthetically Lethal Genes in the Presence of Protein Folding Stress in Lung Cancer In Vivo," will support advanced biomedical research focused on transforming healthcare for military service members and the broader public. The research, to be...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,225,171 to The Leland Stanford Junior University to conduct research on the early detection of kidney cancer using tumor-educated platelets. The performance period for this award runs from August 1, 2024 to July 31, 2028. As a leading private research institution, Stanford University will leverage its expertise in medicine, engineering, and...